Cargando…
CXCR3: Here to stay to enhance cancer immunotherapy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945198/ https://www.ncbi.nlm.nih.gov/pubmed/31690542 http://dx.doi.org/10.1016/j.ebiom.2019.09.044 |
| _version_ | 1783485129520316416 |
|---|---|
| author | Rogava, Meri Izar, Benjamin |
| author_facet | Rogava, Meri Izar, Benjamin |
| author_sort | Rogava, Meri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6945198 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69451982020-01-09 CXCR3: Here to stay to enhance cancer immunotherapy? Rogava, Meri Izar, Benjamin EBioMedicine Commentary Elsevier 2019-11-02 /pmc/articles/PMC6945198/ /pubmed/31690542 http://dx.doi.org/10.1016/j.ebiom.2019.09.044 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Rogava, Meri Izar, Benjamin CXCR3: Here to stay to enhance cancer immunotherapy? |
| title | CXCR3: Here to stay to enhance cancer immunotherapy? |
| title_full | CXCR3: Here to stay to enhance cancer immunotherapy? |
| title_fullStr | CXCR3: Here to stay to enhance cancer immunotherapy? |
| title_full_unstemmed | CXCR3: Here to stay to enhance cancer immunotherapy? |
| title_short | CXCR3: Here to stay to enhance cancer immunotherapy? |
| title_sort | cxcr3: here to stay to enhance cancer immunotherapy? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945198/ https://www.ncbi.nlm.nih.gov/pubmed/31690542 http://dx.doi.org/10.1016/j.ebiom.2019.09.044 |
| work_keys_str_mv | AT rogavameri cxcr3heretostaytoenhancecancerimmunotherapy AT izarbenjamin cxcr3heretostaytoenhancecancerimmunotherapy |